세계의 금연 및 탈니코틴 중독 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Smoking Cessation and Nicotine De-Addiction Market size is anticipated to grow from USD 32.95 Billion in 2024 to USD 82 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.66% during the forecast period of 2026 to 2033.

The smoking cessation and nicotine de-addiction market is witnessing a paradigm shift as public health initiatives and growing awareness of the dangers of smoking drive demand for effective cessation solutions. With an increasing number of individuals seeking to quit smoking, the market for nicotine replacement therapies (NRTs), prescription medications, and behavioral support programs is expanding. This growth is further fueled by the rising prevalence of smoking-related health issues, prompting governments and healthcare organizations to invest in comprehensive smoking cessation programs that provide support and resources for individuals looking to quit.

Moreover, the advent of digital health technologies is transforming the smoking cessation landscape. Mobile applications and online platforms are emerging as valuable tools that offer personalized support, tracking, and motivation for individuals on their journey to quit smoking. These digital solutions often incorporate behavioral science principles, providing users with tailored strategies to manage cravings and triggers. As technology continues to evolve, the integration of artificial intelligence and machine learning into these platforms will enhance their effectiveness, enabling more precise interventions and support for users.

Additionally, the increasing popularity of alternative nicotine delivery systems, such as e-cigarettes and heated tobacco products, is reshaping the smoking cessation market. While these products are often marketed as less harmful alternatives, they still pose challenges for public health. As regulatory bodies assess the long-term effects of these alternatives, the smoking cessation market will need to adapt, offering comprehensive solutions that address the diverse needs of individuals seeking to quit. The smoking cessation and nicotine de-addiction market is thus positioned for significant growth, driven by innovation, technology, and a collective commitment to improving public health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

• Nicotine Replacement Therapy
• Drug Therapy
• E-cigarettes

By Form

• Gum
• Inhaler
• Tablet
• Others

By Distribution Channel

• Hospital Pharmacies
• Online
• Drug Stores and Retail Pharmacies
• COMPANIES PROFILED
• Rusan Pharma Ltd
• Dr. Reddy's Laboratories Ltd
• Imperial Brands Plc
• Zydus Group.
• British American Tobacco Plc
• Perrigo Company Plc
• Johnson and Johnson Inc
• NJOY LLC
• Cipla Ltd
• GlaxoSmithKline Plc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Form
  • 3.7.3 Market Attractiveness Analysis By Distribution Channel
  • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Nicotine Replacement Therapy Historic and Forecast Sales By Regions
• 5.4. Drug Therapy Historic and Forecast Sales By Regions
• 5.5. E-cigarettes Historic and Forecast Sales By Regions

6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY FORM

• 6.1. Overview By Form
• 6.2. Historical and Forecast Data Analysis By Form
• 6.3. Gum Historic and Forecast Sales By Regions
• 6.4. Inhaler Historic and Forecast Sales By Regions
• 6.5. Tablet Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1. Overview By Distribution Channel
• 7.2. Historical and Forecast Data Analysis By Distribution Channel
• 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 7.4. Online Historic and Forecast Sales By Regions
• 7.5. Drug Stores and Retail Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SMOKING CESSATION AND NICOTINE DE-ADDICTION COMPANIES

• 9.1. Smoking Cessation and Nicotine De-Addiction Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Rusan Pharma Ltd
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Dr. Reddy'S Laboratories Ltd
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Imperial Brands Plc
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Zydus Group.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. British American Tobacco Plc
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Perrigo Company Plc
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Johnson And Johnson Inc
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. NJOY LLC
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Cipla Ltd
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. GlaxoSmithKline Plc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies